The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to $430m in funding from ...

The startup will also use its generative AI technology to optimize manufacturing of the gene therapy, leveraging data that MeiraGTx has amassed over the course of nearly a decade developing its ...

Spatial transcriptomics is an advanced technique that analyzes gene expression within tissue sections, such as those from the ...

Medicine and other sciences stand to gain much from this technology, thanks to their data-heavy work and demand for speed and accuracy. In these fields, gene editing is a particularly promising use ...

Traditional methods for identifying therapeutic gene targets, crucial for personalized medicine, are expensive and time-consuming. While artificial intelligence (AI), particularly deep learning ...

Artificial intelligence company Hologen AI has committed up to $430 million as part of a multifaceted agreement to help take MeiraGTx’s Parkinson’s disease gene therapy all the way to market.

Gene therapy specialist MeiraGTx is spinning some of its experimental medicines for the central nervous system into a startup that hopes to develop them further using artificial intelligence. Aptly ...

The biopharmaceutical landscape stands at the cusp of a transformative era, with artificial intelligence (AI) leading the charge. For gene therapy developers, every key milestone significantly ...

This iterative, human-in-the-loop process allowed for refinement of the AI-generated assessments. This process, although more labor-intensive, provides a level of scrutiny and validation essential for ...

a gene therapy for Parkinson’s disease. The agreement, which will also expand the firm’s manufacturing operations, is valued at up to $430 million. It includes the creation of a joint venture, Hologen ...

The new AI model leverages hypergraphs to quickly and accurately identify therapeutic gene targets for diseases BUSAN, South Korea, March 6, 2025 /PRNewswire/ -- Identifying therapeutic gene ...